Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
BJOG ; 129(12): e75-e88, 2022 11.
Article in English | MEDLINE | ID: mdl-35765760

ABSTRACT

The thyroid is a gland located in the neck and is important for many processes in the body. Problems with the thyroid gland are common in women of reproductive age. It is essential to have a normal working thyroid gland in order to achieve a successful pregnancy. One of the most common problems with the thyroid is underactivity (known as hypothyroidism). An early, mild form of an underactive thyroid is called subclinical hypothyroidism. Often people with this condition do not have any symptoms. Another common problem is thyroid autoimmunity. Here, the immune system attacks the thyroid gland, sometimes leading to the development of abnormal thyroid function. This can be diagnosed by the presence of proteins in the bloodstream called antibodies. Mild thyroid problems and the presence of high levels of thyroid antibodies have been linked to miscarriage and premature birth. There is debate in medicine about whether there should be routine testing of thyroid function both in the general population and in individuals who are trying for a baby. In addition, the strategies used to manage certain thyroid problems are questioned. Discussions around testing and subsequent management particularly relate to women with a history of subfertility or repeated miscarriages. This Scientific Impact Paper provides information on thyroid testing and the management of mild thyroid problems and thyroid antibodies in women with a history of subfertility or recurrent miscarriages, using the latest evidence and guidelines. It concludes that there may be a role for treating these women with thyroxine tablets (the hormone produced by the thyroid gland) when subclinical hypothyroidism is present, and gives guidance on the cut-off levels for treatment.


Subject(s)
Abortion, Habitual , Hypothyroidism , Infertility , Pregnancy Complications , Abortion, Habitual/diagnosis , Abortion, Habitual/etiology , Autoantibodies/therapeutic use , Female , Humans , Hypothyroidism/complications , Hypothyroidism/diagnosis , Pregnancy , Pregnancy Complications/drug therapy , Thyroxine
2.
Am J Perinatol ; 35(2): 163-169, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28847038

ABSTRACT

OBJECTIVE: The aim of the present study was to develop a toolkit combining various risk factors to predict the risk of developing a postpartum hemorrhage (PPH) during a cesarean delivery. STUDY DESIGN: A retrospective cohort study of 24,230 women who had cesarean delivery between January 2003 and December 2013 at a tertiary care teaching hospital within the United Kingdom serving a multiethnic population. Data were extracted from hospital databases, and risk factors for PPH were identified. Hothorn et al recursive partitioning algorithm was used to infer a conditional decision tree. For each of the identified combinations of risk factors, two probabilities were calculated: the probability of a patient producing ≥1,000 and ≥ 2,000 mL blood loss. RESULTS: The Leicester PPH predict score was then tested on the randomly selected remaining 25% (n = 6,095) of the data for internal validity. Reliability testing showed an intraclass correlation of 0.98 and mean absolute error of 239.8 mL with the actual outcome. CONCLUSION: The proposed toolkit enables clinicians to predict the risk of postpartum hemorrhage. As a result, preventative measures for postpartum hemorrhage could be undertaken. Further external validation of the current toolkit is required.


Subject(s)
Cesarean Section/adverse effects , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Postpartum Hemorrhage/diagnosis , Postpartum Hemorrhage/epidemiology , Adult , Female , Humans , Pregnancy , Reproducibility of Results , Retrospective Studies , Risk Assessment/methods , Risk Factors , Tertiary Care Centers , United Kingdom/epidemiology
3.
Int J Health Plann Manage ; 33(1): e228-e237, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28858423

ABSTRACT

OBJECTIVE: The objective of this study was to investigate the relationship between cost and quality within the health care sector and to establish which factors could influence this relationship. The aim was to investigate the dynamics of the relationship, in order to improve the quality whilst reducing the cost. DESIGN: This is a retrospective cohort study, analysing quality, safety, and financial data from a 5-year period. SETTING: A publicly funded tertiary hospital. PARTICIPANTS: The dependent variable was cost saved, and the independent variables were patient safety, patient satisfaction, and clinical efficiency. MAIN OUTCOME MEASURES: Financial savings and quality domains. RESULTS: A statistically significant relationship between the variables was found. Multivariate analysis derived the equation Y = ßX1  + c, where Y is the cost saved, ß is the beta coefficient, X1 is the clinical efficiency, and c is a constant. R2 = 0.874 (coefficient of determination), which suggested that the cost saved by the unit varied due to clinical efficiency. Clinical efficiency accounted for 87.4% of the variation in the cost saved by the unit. CONCLUSIONS: The results indicated that, after the trade-off value, an improvement in the quality would result in reduced costs for the unit. Clinical efficiency of the services was found to be the key factor determining this relationship. Therefore, strategies to increase clinical efficiency, and thus overall quality, above the trade-off level could result in significant financial savings. Patient safety and patient experience were positively correlated with clinical efficiency.


Subject(s)
Cost Control/economics , Delivery of Health Care/economics , Quality Improvement/economics , Cost Control/organization & administration , Delivery of Health Care/organization & administration , Delivery of Health Care/standards , Efficiency, Organizational/economics , Efficiency, Organizational/standards , Financing, Organized/economics , Financing, Organized/organization & administration , Humans , Patient Safety/economics , Patient Safety/standards , Patient Satisfaction/economics , Quality Improvement/organization & administration , Quality Indicators, Health Care , Retrospective Studies , Tertiary Care Centers/economics , Tertiary Care Centers/organization & administration
5.
Simul Healthc ; 11(5): 340-344, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27388865

ABSTRACT

INTRODUCTION: Ultrasonography is a core skill required by all obstetrics and gynecology trainees; however, training opportunities in clinical ultrasound are declining. Simulation ultrasound training has been proposed as a strategy to overcome this.The study aims were to determine the current availability of clinical and simulation ultrasound training in obstetrics and gynecology in the United Kingdom and to explore the trainees' perspective on the role of ultrasound simulation. METHODS: All obstetrics and gynecology trainees within the East Midlands Local Education Training Board in the United Kingdom were asked to complete an anonymous web-based survey in July 2014. RESULTS: Of 140 trainees, 70 (50%) responded to the survey, and 69% reported rarely having dedicated clinical ultrasound sessions. Fifty percent had failed to achieve ultrasound competencies required for their stage of training, and 83% felt that the pressures of service provision limited their exposure to clinical ultrasound.Seventy-three percent of the trainees considered ultrasound simulation to be an essential component of training, and 69% agreed that it would help improve their clinical skills. Only 50% had access to an ultrasound simulator. Seventy-seven percent of the trainees thought that it would be useful to have ultrasound simulation integrated into training. CONCLUSIONS: Trainees are struggling to achieve minimal ultrasound competences with clinical ultrasound training alone. They believe that ultrasound simulation will shorten the learning curve and improve their clinical skills and knowledge. Despite the cost implications of simulation training, we propose that consideration is given to formal integration of ultrasound simulation into the curriculum as a possible way forward.


Subject(s)
Gynecology/education , Obstetrics/education , Simulation Training , Ultrasonography , Health Knowledge, Attitudes, Practice , Surveys and Questionnaires , United Kingdom
6.
Int J Gynaecol Obstet ; 133(2): 156-8, 2016 May.
Article in English | MEDLINE | ID: mdl-26892692

ABSTRACT

OBJECTIVE: To evaluate and compare obstetric complications between women who conceived after oocyte donation and age-matched control women who conceived spontaneously or by autologous in vitro fertilization (IVF). METHODS: In a retrospective cohort study, data were assessed from all women who conceived after oocyte donation and delivered a live neonate after 24weeks of pregnancy between January 2007 and December 2014 at a UK hospital. Two age-matched control groups-one containing women who conceived after autologous IVF and the other containing women who conceived spontaneously-were used for comparison. The primary study outcome was hypertensive disorders of pregnancy (pregnancy-induced hypertension and pre-eclampsia). Multivariate analysis was performed by logistic regression. RESULTS: Each group included 45 women. Hypertensive disorders in pregnancy affected 15 (33%) women in the study group, 3 (7%) women who conceived after autologous IVF, and 3 (7%) who conceived spontaneously. The risk of hypertensive disorders in pregnancy was significantly higher in the donor oocyte group (odds ratio 5.85, 95% confidence interval 1.42-23.9; P=0.01). CONCLUSION: Women who conceived after oocyte donation had an increased risk of hypertensive disorders. Oocyte donation should be managed as an independent risk factor, and couples should be counselled appropriately.


Subject(s)
Fertilization in Vitro/adverse effects , Hypertension, Pregnancy-Induced/epidemiology , Oocyte Donation/adverse effects , Pre-Eclampsia/epidemiology , Pregnancy Complications/epidemiology , Pregnancy Outcome/epidemiology , Adult , Female , Fetal Growth Retardation/epidemiology , Humans , Hypertension, Pregnancy-Induced/etiology , Infant, Newborn , Logistic Models , Maternal Age , Middle Aged , Multivariate Analysis , Odds Ratio , Pre-Eclampsia/etiology , Pregnancy , Pregnancy Complications/etiology , Premature Birth/epidemiology , Retrospective Studies , Risk Factors , United Kingdom
7.
Sex Transm Infect ; 92(6): 474-9, 2016 09.
Article in English | MEDLINE | ID: mdl-26792088

ABSTRACT

BACKGROUND: The human papillomavirus (HPV) vaccine is recommended for adolescent girls in many European countries, however there is huge variation in vaccine uptake. METHODS: A mixed methods systematic review to ascertain the level of HPV and HPV vaccine knowledge that exists among European adolescents. Two electronic databases, Ovid Medline and PsychInfo, were searched from origin to September 2014. Meta-analysis was performed for the two primary outcome measures ('have you heard of HPV?' and 'have you heard of the HPV vaccine?'), assessing for the correlation between gender and knowledge. This was supplemented with meta-synthesis for the remaining associations and secondary outcomes. RESULTS: 18 papers were included in the final review. Overall European adolescents had poor understanding of basic HPV and HPV vaccine knowledge. Meta-analysis identified that female adolescents are more likely to have heard of HPV (n=2598/5028 girls versus n=1033/3464 boys; OR 2.73, 95% CI 1.86-3.99) and the HPV vaccine (n=1154/2556 girls versus n=392/2074 boys; OR 5.64, 95% CI 2.43-13.07), compared to males. Age, higher education and a positive vaccination status were also associated with increased awareness. There was limited appreciation of more detailed HPV knowledge and uncertainty existed regarding the level of protection offered by the vaccine and the need for cervical screening post vaccination. CONCLUSIONS: The delivery of HPV education to European adolescents needs to be re-evaluated, since at present there appears to be significant deficiencies in their basic knowledge and understanding of the subject. Increasing HPV knowledge will empower adolescents to make informed choices regarding participation with HPV related cancer prevention health strategies.


Subject(s)
Health Knowledge, Attitudes, Practice , Papillomaviridae , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines , Patient Acceptance of Health Care/statistics & numerical data , Reproductive Health , Uterine Cervical Neoplasms/prevention & control , Adolescent , Europe , Female , Humans , Papillomavirus Infections/virology , Papillomavirus Vaccines/administration & dosage , Parents , Uterine Cervical Neoplasms/virology , Vaccination/statistics & numerical data
8.
Best Pract Res Clin Obstet Gynaecol ; 29(3): 350-64, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25457859

ABSTRACT

This review is aimed at discussing placental dysfunction in obesity and its clinical implication in pregnancy as well as an antenatal surveillance strategy for these women. Maternal obesity is associated with adverse perinatal outcome. Obesity is an independent risk factor for fetal hyperinsulinaemia, birthweight and newborn adiposity. Maternal obesity is associated with childhood obesity and obesity in adult life. Obesity induces a low-grade inflammatory response in placenta, which results in short- and long-term programming of obesity in fetal life. Preconception and antenatal counselling on obstetrics risk in pregnancy, on diet and lifestyle in pregnancy and on gestational weight gain is associated with a better outcome. Fetal growth velocity is closely associated with maternal weight and gestational weight gain. Careful monitoring of gestational weight gain and fetal growth, and screening and management of obstetrical complications such as gestational diabetes and pre-eclampsia, improves perinatal outcome. The use of metformin in non-diabetic obese women is under investigation; further evidence is required before recommending it.


Subject(s)
Inflammation , Obesity , Placenta Diseases , Pregnancy Complications , Diabetes, Gestational/drug therapy , Female , Fetal Development , Humans , Hypoglycemic Agents/therapeutic use , Metformin/therapeutic use , Pre-Eclampsia , Pregnancy , Pregnancy, High-Risk , Prenatal Care , Weight Gain
9.
J Hum Reprod Sci ; 7(3): 159-69, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25395740

ABSTRACT

Recurrent miscarriages are postimplantation failures in natural conception; they are also termed as habitual abortions or recurrent pregnancy losses. Recurrent pregnancy loss is disheartening to the couple and to the treating clinician. There has been a wide range of research from aetiology to management of recurrent pregnancy loss. It is one of the most debated topic among clinicians and academics. The ideal management is unanswered. This review is aimed to produce an evidence-based guidance on clinical management of recurrent miscarriage. The review is structured to be clinically relevant. We have searched electronic databases (PubMed and Embase) using different key words. We have combined the searches and arranged them with the hierarchy of evidences. We have critically appraised the evidence to produce a concise answer for clinical practice. We have graded the evidence from level I to V on which these recommendations are based.

10.
Obstet Gynecol Surv ; 69(2): 109-15, 2014 Feb.
Article in English | MEDLINE | ID: mdl-25112489

ABSTRACT

The diagnosis of unexplained infertility can be made only after excluding common causes of infertility using standard fertility investigations,which include semen analysis, assessment of ovulation, and tubal patency test. These tests have been selected as they have definitive correlation with pregnancy. It is estimated that a standard fertility evaluation will fail to identify an abnormality in approximately 15% to 30% of infertile couples. The reported incidence of such unexplained infertility varies according to the age and selection criteria in the study population. We conducted a review of the literature via MEDLINE. Articles were limited to English-language, human studies published between 1950 and 2013. Since first coined more than 50 years ago, the term unexplained infertility has been a subject of debate. Although additional investigations are reported to explain or define other causes of infertility, these have high false-positive results and therefore cannot be recommended for routine clinical practice. Couples with unexplained infertility might be reassured that even after 12 months of unsuccessful attempts, 50% will conceive in the following 12 months and another 12% in the year after.


Subject(s)
Infertility/epidemiology , Female , Humans , Infertility/diagnosis , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...